DK2061444T3 - Sammensætninger og fremgangsmåder til behandling, kontrol, reducering, forbedring eller forebyggelse af allergi - Google Patents
Sammensætninger og fremgangsmåder til behandling, kontrol, reducering, forbedring eller forebyggelse af allergiInfo
- Publication number
- DK2061444T3 DK2061444T3 DK07841298.8T DK07841298T DK2061444T3 DK 2061444 T3 DK2061444 T3 DK 2061444T3 DK 07841298 T DK07841298 T DK 07841298T DK 2061444 T3 DK2061444 T3 DK 2061444T3
- Authority
- DK
- Denmark
- Prior art keywords
- allergy
- prevention
- compositions
- improvement
- reduction
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 206010020751 Hypersensitivity Diseases 0.000 title abstract 2
- 208000026935 allergic disease Diseases 0.000 title abstract 2
- 230000007815 allergy Effects 0.000 title abstract 2
- 230000002265 prevention Effects 0.000 title 1
- 230000003266 anti-allergic effect Effects 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- JFUAWXPBHXKZGA-IBGZPJMESA-N 4-fluoro-2-[(4r)-5,5,5-trifluoro-4-hydroxy-2-methyl-4-(1h-pyrrolo[2,3-c]pyridin-2-ylmethyl)pentan-2-yl]phenol Chemical compound C([C@@](O)(CC=1NC2=CN=CC=C2C=1)C(F)(F)F)C(C)(C)C1=CC(F)=CC=C1O JFUAWXPBHXKZGA-IBGZPJMESA-N 0.000 abstract 1
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 abstract 1
- 230000001387 anti-histamine Effects 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000000739 antihistaminic agent Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 229940124750 glucocorticoid receptor agonist Drugs 0.000 abstract 1
- 210000003630 histaminocyte Anatomy 0.000 abstract 1
- 239000002955 immunomodulating agent Substances 0.000 abstract 1
- 230000002584 immunomodulator Effects 0.000 abstract 1
- 229940121354 immunomodulator Drugs 0.000 abstract 1
- 238000002513 implantation Methods 0.000 abstract 1
- 238000002347 injection Methods 0.000 abstract 1
- 239000007924 injection Substances 0.000 abstract 1
- 239000003199 leukotriene receptor blocking agent Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- 230000000699 topical effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84362906P | 2006-09-11 | 2006-09-11 | |
| PCT/US2007/076701 WO2008033655A2 (en) | 2006-09-11 | 2007-08-24 | Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2061444T3 true DK2061444T3 (da) | 2011-06-27 |
Family
ID=38819731
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07841298.8T DK2061444T3 (da) | 2006-09-11 | 2007-08-24 | Sammensætninger og fremgangsmåder til behandling, kontrol, reducering, forbedring eller forebyggelse af allergi |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US20080064721A1 (da) |
| EP (1) | EP2061444B1 (da) |
| JP (1) | JP2010502723A (da) |
| KR (1) | KR20090050076A (da) |
| CN (1) | CN101553214B (da) |
| AT (1) | ATE506061T1 (da) |
| AU (1) | AU2007297054A1 (da) |
| BR (1) | BRPI0716625A2 (da) |
| CA (1) | CA2661197C (da) |
| DE (1) | DE602007014067D1 (da) |
| DK (1) | DK2061444T3 (da) |
| ES (1) | ES2361585T3 (da) |
| MX (1) | MX2009002544A (da) |
| PL (1) | PL2061444T3 (da) |
| PT (1) | PT2061444E (da) |
| TW (1) | TWI344467B (da) |
| WO (1) | WO2008033655A2 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20090087443A1 (en) * | 2007-09-27 | 2009-04-02 | Bartels Stephen P | Pharmacological Adjunctive Treatment Associated with Glaucoma Filtration Surgery |
| ES2402321T3 (es) * | 2007-11-05 | 2013-04-30 | Bausch & Lomb Incorporated | Materiales inmiscibles en agua como vehículos para el suministro de fármacos |
| US8263581B2 (en) | 2009-07-03 | 2012-09-11 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
| US8513259B2 (en) | 2009-07-03 | 2013-08-20 | Jdp Therapeutics, Inc. | Non-sedating antihistamine injection formulations and methods of use thereof |
| WO2013126156A1 (en) * | 2012-02-22 | 2013-08-29 | Bausch & Lomb Incorporated | Nitric oxide donating selective glucocorticoid receptor agonist compounds and ophthalmic compositions |
| EP3914249B1 (en) | 2019-01-22 | 2024-05-01 | Akribes Biomedical GmbH | Selective glucocorticoid receptor modifiers for treating impaired skin wound healing |
Family Cites Families (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5449760A (en) * | 1987-12-31 | 1995-09-12 | Tanox Biosystems, Inc. | Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils |
| US5614611A (en) * | 1987-12-31 | 1997-03-25 | Tanox Biosystems, Inc. | Humanized monoclonal antibodies binding to IgE-bearing B cells but not basophils |
| US5378475A (en) * | 1991-02-21 | 1995-01-03 | University Of Kentucky Research Foundation | Sustained release drug delivery devices |
| ATE164079T1 (de) * | 1994-01-18 | 1998-04-15 | Genentech Inc | Verfahren zur behandlung von parasitären infektionen unter verwendung von ige-antagonisten |
| US6051576A (en) * | 1994-01-28 | 2000-04-18 | University Of Kentucky Research Foundation | Means to achieve sustained release of synergistic drugs by conjugation |
| US5773019A (en) * | 1995-09-27 | 1998-06-30 | The University Of Kentucky Research Foundation | Implantable controlled release device to deliver drugs directly to an internal portion of the body |
| US5902598A (en) * | 1997-08-28 | 1999-05-11 | Control Delivery Systems, Inc. | Sustained release drug delivery devices |
| US6242196B1 (en) | 1997-12-11 | 2001-06-05 | Dana-Farber Cancer Institute | Methods and pharmaceutical compositions for inhibiting tumor cell growth |
| WO2000000194A1 (en) | 1998-06-27 | 2000-01-06 | Photogenesis, Inc. | Ophthalmic uses of ppargamma agonists and ppargamma antagonists |
| PL355101A1 (en) * | 1999-11-18 | 2004-04-05 | Alcon Inc. | Use of h1 |
| US6726918B1 (en) * | 2000-07-05 | 2004-04-27 | Oculex Pharmaceuticals, Inc. | Methods for treating inflammation-mediated conditions of the eye |
| WO2003059899A1 (en) * | 2002-01-14 | 2003-07-24 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical formulations containing them and uses thereof |
| US7268152B2 (en) * | 2002-03-26 | 2007-09-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| WO2003082280A1 (en) * | 2002-03-26 | 2003-10-09 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| US6897224B2 (en) * | 2002-04-02 | 2005-05-24 | Schering Ag | Quinoline and isoquinoline derivatives, a process for their production and their use as inflammation inhibitors |
| US7074806B2 (en) * | 2002-06-06 | 2006-07-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| SI1521733T1 (sl) * | 2002-07-08 | 2014-10-30 | Pfizer Products Inc. | Modulatorji glukokortikoidnega receptorja |
| US7579469B2 (en) * | 2003-01-03 | 2009-08-25 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| US20040224992A1 (en) * | 2003-02-27 | 2004-11-11 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| WO2004097410A1 (en) * | 2003-04-30 | 2004-11-11 | Pfizer Products Inc. | Screening methods for cataractogenic risk |
| UY28526A1 (es) * | 2003-09-24 | 2005-04-29 | Boehringer Ingelheim Pharma | Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos |
| US7795272B2 (en) * | 2004-03-13 | 2010-09-14 | Boehringer Ingelheim Pharmaceutical, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof |
| EP1730145A1 (en) * | 2004-03-22 | 2006-12-13 | Boehringer Ingelheim Pharmaceuticals Inc. | Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics |
| US7417056B2 (en) * | 2004-11-12 | 2008-08-26 | Schering Ag | 5-substituted quinoline and isoquinoline derivatives, a process for their production and their use as anti-inflammatory agents |
| DE102004055633A1 (de) | 2004-11-12 | 2006-05-18 | Schering Ag | 5-substituierte Chinolin- und Isochinolin-Derivate, ein Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
| ES2414479T3 (es) * | 2005-04-14 | 2013-07-19 | Glaxo Group Limited | Indazoles como ligandos del receptor de glucocorticoides |
-
2007
- 2007-08-24 DE DE602007014067T patent/DE602007014067D1/de active Active
- 2007-08-24 AT AT07841298T patent/ATE506061T1/de active
- 2007-08-24 DK DK07841298.8T patent/DK2061444T3/da active
- 2007-08-24 ES ES07841298T patent/ES2361585T3/es active Active
- 2007-08-24 CA CA2661197A patent/CA2661197C/en not_active Expired - Fee Related
- 2007-08-24 PL PL07841298T patent/PL2061444T3/pl unknown
- 2007-08-24 CN CN2007800410004A patent/CN101553214B/zh not_active Expired - Fee Related
- 2007-08-24 WO PCT/US2007/076701 patent/WO2008033655A2/en not_active Ceased
- 2007-08-24 AU AU2007297054A patent/AU2007297054A1/en not_active Abandoned
- 2007-08-24 MX MX2009002544A patent/MX2009002544A/es active IP Right Grant
- 2007-08-24 EP EP07841298A patent/EP2061444B1/en not_active Not-in-force
- 2007-08-24 JP JP2009527486A patent/JP2010502723A/ja active Pending
- 2007-08-24 BR BRPI0716625-7A patent/BRPI0716625A2/pt not_active IP Right Cessation
- 2007-08-24 PT PT07841298T patent/PT2061444E/pt unknown
- 2007-08-24 KR KR1020097005001A patent/KR20090050076A/ko not_active Ceased
- 2007-09-05 US US11/850,152 patent/US20080064721A1/en not_active Abandoned
- 2007-09-10 TW TW096133714A patent/TWI344467B/zh not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| MX2009002544A (es) | 2009-03-20 |
| AU2007297054A1 (en) | 2008-03-20 |
| KR20090050076A (ko) | 2009-05-19 |
| JP2010502723A (ja) | 2010-01-28 |
| PL2061444T3 (pl) | 2011-09-30 |
| TWI344467B (en) | 2011-07-01 |
| WO2008033655A2 (en) | 2008-03-20 |
| EP2061444A2 (en) | 2009-05-27 |
| CN101553214A (zh) | 2009-10-07 |
| TW200819442A (en) | 2008-05-01 |
| US20080064721A1 (en) | 2008-03-13 |
| CN101553214B (zh) | 2012-12-26 |
| ES2361585T3 (es) | 2011-06-20 |
| EP2061444B1 (en) | 2011-04-20 |
| WO2008033655A3 (en) | 2008-10-02 |
| DE602007014067D1 (de) | 2011-06-01 |
| CA2661197C (en) | 2012-01-03 |
| ATE506061T1 (de) | 2011-05-15 |
| PT2061444E (pt) | 2011-07-08 |
| BRPI0716625A2 (pt) | 2013-10-08 |
| CA2661197A1 (en) | 2008-03-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4616913A3 (en) | Gcn2 inhibitors and uses thereof | |
| DK2061444T3 (da) | Sammensætninger og fremgangsmåder til behandling, kontrol, reducering, forbedring eller forebyggelse af allergi | |
| UA94909C2 (ru) | Фармацевтическая композиция нейроактивного стероида и ее применение | |
| DK1480634T3 (da) | Selektive androgenreceptormodulatorer (SARM) til behandling af benign prostatahyperplasi | |
| IL197574A0 (en) | Pharmaceutical compositions | |
| NO20090119L (no) | Sammensetning omfattende nanopartikulaert meloxicam og hydrokodon med kontrollert frigivelse | |
| WO2007101005A3 (en) | Compositions and methods for effecting controlled posterior vitreous detachment | |
| NO20023473D0 (no) | Sammensetninger for levering av en kortisol antagonist | |
| WO2008034796A3 (en) | Estratriene derivatives and their uses as 17beta-hydr0xyster0id dehydrogenase inhibitors | |
| WO2007143557A3 (en) | Compounds and methods for treating mammalian gastrointestinal parasitic infections | |
| WO2008012338A3 (en) | Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions | |
| DK2051710T3 (da) | Sammensætninger og fremgangsmåder til behandling, reducering, forbedring eller lindring af sygdomme i det bageste øjensegment | |
| NO20060328L (no) | Kombinasjon av mGluR2-antagonist og ACHE-inhibitor for behandiing av akutt og/eller kronisk neurologiske forstyrrelser | |
| WO2006074265A3 (en) | Drug combination therapy and pharmaceutical compositions for treating inflammatory disorders | |
| SA523440403B1 (ar) | Magl مثبط | |
| EA200800783A1 (ru) | Композиция тразодона для введения один раз в день | |
| MX2009002228A (es) | Composiciones y metodos para tratar o prevenir glaucoma o el avance del mismo. | |
| MX2013014518A (es) | Composiciones y metodos para tratar, controlar, reducir, o mejorar el dolor inflamatorio. | |
| MX2010001370A (es) | Composiciones que comprenden agonista del receptor glucocorticoide disociado para tratar o controlar inflamacion del segmento anterior. | |
| WO2009047505A3 (en) | Dexanabinol with inhibitors of braf or mek for the treatment of melanoma | |
| NO20073610L (no) | Nye substituerte tiofenpyrimidinonderivater som inhibitorer for 17 β-hydroksysteroiddehydrogenase | |
| NO20070774L (no) | Sammensetninger for behandling av inflammasjon og smerte ved anvendelse av en kombinasjon av en COX-2- selektiv inhibitor og en LTB4 reseptorantagonist | |
| WO2006116582A3 (en) | Pharmaceutical compositions comprising a substituted benzimidazole, buffering agent and vitamin b12 | |
| WO2006116556A3 (en) | Composition comprising proton pump inhibitor and buffer | |
| UA84566C2 (ru) | Производные тиофенпиримидинонов и их применение в терапии, фармацевтическая композиция на их основе |